We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Drug Products » Device Regulation Under Gottlieb & Trump - Webinar Recording/Transcript

Other Options

Audio Recording/Transcript - Oct. 12, 2017

$287.00

Audio Recording/Transcript - Oct. 12, 2017

$258.00

Audio Recording/Transcript - Oct. 12, 2017

$244.00

Audio Recording/Transcript - Oct. 12, 2017

$230.00

Audio Recording/Transcript - Oct. 12, 2017

$215.00

Device Regulation Under Gottlieb & Trump - Webinar Recording/Transcript

$287.00
Drug Products

Product Details

Device Regulation under Gottlieb & Trump

In Part II of FDAnews’s Expert Insight Series, our panel dives deep into device regulation, policy and enforcement.

New device policies will have been established. New Trump-Gottlieb appointees will be taking their seats. Many new devices will have been approved. And it will be coming clear how fundamental standards for approval will differ from the past.

Perhaps most important, policies on product approvals and other key issues will be starting to emerge: Relationships between medical devices and combination products, fast-track approvals, clinical trials, and more.

Given the fluid nature of events though, panelists are certain to range beyond the topic of the day. Other installments include:

  • What We’ve Learned Since Scott Gottlieb Was Confirmed
  • Pharmaceutical Regulation under Gottlieb-Trump
  • The FDA Under Gottlieb-Trump and a Look Ahead

If you are a devicemaker, you know this is the must-attend session. But it makes sense to register for them all. Scott Gottlieb’s FDA is now your FDA.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing